Mahalakshmi Radhakrishnan
Directeur/Membre du Conseil chez ALTO NEUROSCIENCE, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Mahalakshmi Radhakrishnan
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALTO NEUROSCIENCE, INC. | Directeur/Membre du Conseil | 08/03/2024 | - |
Independent Dir/Board Member | 08/03/2024 | - | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Directeur/Membre du Conseil | 29/11/2022 | - |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Directeur/Membre du Conseil | 05/01/2023 | - |
Historique de carrière de Mahalakshmi Radhakrishnan
Anciens postes connus de Mahalakshmi Radhakrishnan
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 | 01/03/2024 |
SANOFI | Corporate Officer/Principal | 01/01/2016 | 01/01/2019 |
BIOASIS TECHNOLOGIES INC. | Directeur/Membre du Conseil | 21/09/2017 | 27/07/2018 |
Independent Dir/Board Member | 21/09/2017 | 27/07/2018 | |
BIOGEN INC. | Corporate Officer/Principal | 01/04/2013 | 01/10/2016 |
Bristol-Myers Squibb Holdings Pharma LLC
Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Pharma Ltd. engages in the pharmaceutical company. The company is headquartered in San Juan, Puerto Rico. | Directeur/Membre du Conseil | 01/02/2009 | 01/04/2013 |
Corporate Officer/Principal | 01/02/2009 | 01/04/2013 | |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/11/2016 | - |
Formation de Mahalakshmi Radhakrishnan
Peoples' Friendship University of Russia | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
France | 2 |
Russie | 2 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 2 |
Sectorielle
Health Technology | 8 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
BIOGEN INC. | Health Technology |
SANOFI | Health Technology |
BIOASIS TECHNOLOGIES INC. | Health Technology |
ALTO NEUROSCIENCE, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Bristol-Myers Squibb Holdings Pharma LLC
Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Pharma Ltd. engages in the pharmaceutical company. The company is headquartered in San Juan, Puerto Rico. | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Commercial Services |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Health Technology |
- Bourse
- Insiders
- Mahalakshmi Radhakrishnan
- Expérience